Ste 380 MC 5882
Palo Alto, CA 94304
Facsímil: (650) 723-5201
My approach to medical care is to listen to each individual story from both the child and the family, engage them in open discussion, and provide them with evidence-based medicine to empower them to navigate their health care decisions. Open and ongoing communication with children and their families is fundamental, as well as a team-based approach with all health care providers involved in the care of the child. The child and the family are the most important players on our team!
I am proud to be able to build long-lasting relationships with children and their families. Nothing gives me more joy than seeing a smile on a child’s face at the end of his or her appointment.
I became a physician because of the many roles I have and enjoy doing. People may view physicians as only medical experts, but other fun parts of being a physician are being a teacher, a constant learner as medicine is ever-changing, a collaborator, a scholar, and a health advocate for my patients and families. I chose to specialize in pediatric pulmonology because the intricacies in the way our lungs function fascinate me.
Boston University School of Medicine, Boston, MA, 06/01/2008
UCSF Benioff Childrens Hospital Pediatric Residency, Oakland, CA, 06/30/2011
UCSF Benioff Childrens Hospital Pediatric Pulmonary Fellowship, Oakland, CA, United States of America, 06/30/2015
Pediatric Pulmonary, American Board of Pediatrics
Pediatrics, American Board of Pediatrics
BACKGROUND: Heated and humidified high flow nasal cannula oxygen therapy has been used in children with severe bronchiolitis. No data exists in children with mild to moderate bronchiolitis requiring lower flows of heated and humidified oxygen therapy.METHODS: We conducted a prospective, randomized pilot study of standard dry oxygen (control) versus heated and humidified low flow nasal cannula (HHLFNC),<4 liters per minute (LPM) oxygen, (treatment) in healthy children 24 months old with bronchiolitis. Clinical assessments were made using Respiratory Distress Assessment Instrument (RDAI), respiratory rate (RR), and oxygen saturation.RESULTS: Thirty-two children were enrolled (16 participants in each group). There was no significant difference in mean RDAI over time between groups. There was a significant difference in mean RDAI over time within control group, at hour 12, and treatment group, at hour 1, compared to baseline. RDAI in the treatment group was overall lower over time compared to control group. There was no significant difference in mean RR over time between or within groups, between mean length of stay and duration of oxygen requirement. Subgroup analyses showed lower RDAI in subjects that had RSV infection, male gender, and non-black race.CONCLUSIONS: The use of HHLFNC oxygen therapy may provide more comfort and may result in more rapid improvements in RDAI compared to standard dry oxygen therapy over time. HHFLNC is safe and well tolerated compared to standard dry oxygen. Larger studies are needed to assess the clinical efficacy of HHLFNC oxygen therapy.
View details for PubMedID 30887708